Pregnancy outcomes of women who received conservative therapy for endometrial carcinoma or atypical endometrial hyperplasia

Abstract Case Approximately 3%‐25% of cases of endometrial carcinoma (EC) or atypical endometrial hyperplasia (AH) occur in women aged <40 years and conservative treatment with high‐dose medroxyprogesterone acetate (MPA) is administered to women who wish to preserve their fertility. Here is repor...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Toshiya Matsuzaki, Takeshi Iwasa, Takako Kawakita, Yuri Yamamoto, Akiko Abe, Aki Hayashi, Kiyohito Yano, Masato Nishimura, Akira Kuwahara, Minoru Irahara
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Wiley 2018-07-01
Reeks:Reproductive Medicine and Biology
Onderwerpen:
assisted reproductive technology
atypical endometrial hyperplasia
conservative treatment
endometrial carcinoma
medroxyprogesterone acetate
Online toegang:https://doi.org/10.1002/rmb2.12209
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items